Stay updated on HER2 Therapy+Fulvestrant/Capecitabine in HR+/HER2+ MBC Clinical Trial
Sign up to get notified when there's something new on the HER2 Therapy+Fulvestrant/Capecitabine in HR+/HER2+ MBC Clinical Trial page.

Latest updates to the HER2 Therapy+Fulvestrant/Capecitabine in HR+/HER2+ MBC Clinical Trial page
- Check5 days agoNo Change Detected
- Check12 days agoChange DetectedRevision tag on the study page was updated from v3.6.2 to v3.6.3. This indicates a small version update to the page metadata rather than a content change.SummaryDifference0.0%

- Check19 days agoChange DetectedThe page revision label was updated from v3.6.0 to v3.6.2, indicating a small update to the page rendering.SummaryDifference0.0%

- Check33 days agoChange DetectedThe study record was updated to standardize the Intervention/Treatment heading, add the investigator name Xuexin He and last-verified status, and include new help sections (How to Read a Study Record, Common Questions, How to Join a Study) with a revision tag Revision: v3.6.0. Removed the older items 'Intervention / Treatment', the full investigator attribution ('xuexin he, Second Affiliated Hospital, School of Medicine, Zhejiang University'), and the previous revision tag (Revision: v3.5.5).SummaryDifference1%

- Check41 days agoChange DetectedThe page now displays Revision: v3.5.5, replacing the previous v3.5.4. This indicates a minor backend or UI update rather than a change to study details.SummaryDifference0.0%

- Check62 days agoChange DetectedThe page now shows Revision: v3.5.4, indicating a small release of the site software; no study data or visible content changes are introduced.SummaryDifference0.0%

- Check69 days agoChange DetectedA Last known status entry was added, listing the investigator and affiliation with a date and verification status. This update adds metadata about who last verified the record and when.SummaryDifference0.4%

Stay in the know with updates to HER2 Therapy+Fulvestrant/Capecitabine in HR+/HER2+ MBC Clinical Trial
Enter your email address, and we'll notify you when there's something new on the HER2 Therapy+Fulvestrant/Capecitabine in HR+/HER2+ MBC Clinical Trial page.